Dental location research / Product comparison

PayorMap vs ConfiDens Analytics for dental site selection.

ConfiDens Analytics offers dental-specific site and city reports, verified competitor analysis, subscription access and consultation. PayorMap's differentiated ambition is national market selection with payer/CDT reimbursement context; those claims remain subject to its research quality gates.

The distinction

A local dental site study and a national reimbursement-aware shortlist serve different stages.

Where ConfiDens Analytics is strongest

Dentists looking for address-level or city-wide dental demographic analysis, competitor verification and advisor support.

  • Analyzes individual locations and city-wide markets for dental practice decisions.
  • Offers human-verified competitor analysis, demographics and a 30-minute consultation on selected studies.
  • Sells a separate subscription and written report options.

Source: ConfiDens — Pricing and Deliverables.

What PayorMap adds—and what it does not

PayorMap combines its existing geographic dental rate and payer/CDT research with demographic and practice-supply screens. These are complementary evidence layers, not a claim that PayorMap duplicates every feature of ConfiDens Analytics.

  • Is designed to screen candidate states and markets nationally before detailed local follow-up.
  • Includes payer/CDT reimbursement observations only when payer, source, network and geography evidence permits responsible comparisons.
  • Must still verify active competitors, attainable payer contracts and final site economics; those cannot be inferred from published data.

Which should you choose?

01Choose the specialist

Choose ConfiDens when an exact address or a single city and human-verified local competitor research are the main priorities.

02Consider the dental rate lens

Consider PayorMap when you're willing to relocate nationally and want a defensible market shortlist informed by dental payer economics.

03Validate the entire decision

A dentist who already picked a property may need a local field study more urgently than a national report.

Price and scope

ConfiDens lists $449 Location Analysis, $1,399 City Location Combo and a $149/month subscription with a three-month minimum. Its FAQ states 5–10 business days for location/city analyses; verify current terms.

Compare the geography, deliverable, methodology, data year, source verification, revision policy and human review actually included—not just the headline fee. PayorMap's national reports are a different scope from a single-property study.

Frequently asked questions

Does ConfiDens offer verified competitor data?

Yes. Its published materials describe real-time and human-verified competitor analysis.

Is PayorMap's 24-hour delivery already guaranteed?

No. PayorMap is developing a payment-triggered research workflow; any delivery target must depend on data validation and an operational fulfillment system.

Which product should I start with?

Use a national screening product if you haven't narrowed the geography; use an address-level study if you're preparing to sign a lease.

Published sources and editorial notes

Reviewed November 10, 2026. Competitor descriptions rely on each vendor's published materials; public pages do not disclose every underlying product capability. PayorMap is not affiliated with, endorsed by or sponsored by ConfiDens Analytics. Names belong to their respective owners.

PayorMap's published payer observations do not establish attainable contract rates, validated active offices, patient demand, collections or a guaranteed successful location. Market-specific report recommendations remain subject to quality approval.

Personalized location intelligence

Find the markets worth investigating.

Compare national markets using demographics, active-practice supply indicators, payer-rate evidence and your priorities. Get a reasoned shortlist with uncertainties made clear—then investigate promising ZIP codes in depth.

Explore my personalized market report

Research availability depends on source quality and review. No guaranteed practice earnings.